S&P 500
1648.80
-3.01 -0.18%
Dow Indu
15289.20
-29.03 -0.19%
Nasdaq
3479.78
-2.40 -0.07%
Crude Oil
98.75
+0.08 +0.08%
Gold
1374.50
+8.17 +0.60%
Euro
1.33921
+0.00011 +0.01%
US Dollar
80.601
-0.086 -0.11%
Strong

New York Mercantile Exchange › (NYMEX:HXE.N12.424C)

(0.00%)

, 30 min delay

 (NYMEX:HXE.N12.424C) $metamarket Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

Fundamentals Can Kill You If You're Not Careful! 18 hours ago
In Precious Metals, Cash Flow Is King 19 hours ago
Trade of the Week Review 1 day ago
Today's Video Update: What Goes Up, Must Come Down...Right? 1 day ago

Today's News

AP Top Extended Financial Headlines At 7:44 a.m. EDT

2 hours, 13 minutes ago

Protalix signs supply deal with Brazilian government for Gaucher disease treatment Study: Wiser medication use could save US $213 billion a year in avoidable health care costs

Protalix signs supply deal with Brazilian govt

2 hours, 25 minutes ago

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease treatment. During the agreement, Protalix will transfer the technology needed for the Brazilian government to build at its own expense a factory to make a sustainable supply of Uplyso. Protalix doesn't have to complete the final stage of its technology transfer until the government has made at least $280 million in Uplyso purchases.

AP Top Extended Financial Headlines At 7:31 a.m. EDT

2 hours, 25 minutes ago

From statement to forecasts to news conference, here's what to watch for from the Fed Dish won't submit revised bid for Sprint; path open for Softbank takeover of wireless carrier

Ahead of the Bell: Adobe Systems

2 hours, 27 minutes ago

Adobe's stock surged in premarket trading Wednesday as the software maker said that its Creative Cloud subscriptions continued to climb in its fiscal second quarter. The San Jose, Calif., company has been shifting its business to a subscription format. It had 700,000 paid subscriptions at the quarter's end.

INO.com on Facebook INO.com MarketClub on Twitter INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.